Pub Date : 2019-11-24DOI: 10.1080/15321819.2019.1694942
Oluwafunmilyo Abosede Ayodele, A. M. Deji-Agboola, P. Akinduti, A. Faneye
ABSTRACT Global prevalence of ESBL-biotypes poses a serious threat to public health as a result of severity and morbidity caused by beta-lactam encoded Escherichia coli. Therefore, the prevalent shiga toxigenic Escherichia coli of ESBL variant was investigated in various retailed food animals and cooking materials. A total of 823 samples consisting of raw meat (297) and fish (132) samples retailed at various major markets in Ibadan were collected and 394 swabs were taken from the butchers’ processing tables and utensils used in retailing meat and fish. The samples were cultured and biotyped for Escherichia coli. Serological and PCR assay were used to identify O157:H7 variant and antibiotics resistant determinants. Genetic relatedness of characterized E. coli O157 from human and meat products was evaluated with phylogenetic analysis. Of all the isolates, 130 (15.8%) were E. coli and only 8 (1.0) were O157:H7 while 4 (50%) were resistant to one or more antibiotics with resistance index ranging from 0.1 to 0.5. More than 25% E. coli O157:H7 were resistant to Ampicillin, Pefloxacin and Gentamicin and blaSHV and blaCTX-M were detected in 1/8 (12.5%) of E. coli O157:H7 and blaTEM 3/8 (37.5%) respectively. Only 1 genotyped human Escherichia coli .0157:H7 clustered with beef strain There is evidence of blaTEM encoded E. coli O157:H7 causing infection in human from food animals retailed in many markets within various communities. Therefore, urgent surveillance with public health education, food, and environmental hygiene are highly needed to prevent its spread.
{"title":"Phylo-diversity of prevalent human E. coli O157:H7 with strains from retailed meat and fish in selected markets in Ibadan Nigeria","authors":"Oluwafunmilyo Abosede Ayodele, A. M. Deji-Agboola, P. Akinduti, A. Faneye","doi":"10.1080/15321819.2019.1694942","DOIUrl":"https://doi.org/10.1080/15321819.2019.1694942","url":null,"abstract":"ABSTRACT Global prevalence of ESBL-biotypes poses a serious threat to public health as a result of severity and morbidity caused by beta-lactam encoded Escherichia coli. Therefore, the prevalent shiga toxigenic Escherichia coli of ESBL variant was investigated in various retailed food animals and cooking materials. A total of 823 samples consisting of raw meat (297) and fish (132) samples retailed at various major markets in Ibadan were collected and 394 swabs were taken from the butchers’ processing tables and utensils used in retailing meat and fish. The samples were cultured and biotyped for Escherichia coli. Serological and PCR assay were used to identify O157:H7 variant and antibiotics resistant determinants. Genetic relatedness of characterized E. coli O157 from human and meat products was evaluated with phylogenetic analysis. Of all the isolates, 130 (15.8%) were E. coli and only 8 (1.0) were O157:H7 while 4 (50%) were resistant to one or more antibiotics with resistance index ranging from 0.1 to 0.5. More than 25% E. coli O157:H7 were resistant to Ampicillin, Pefloxacin and Gentamicin and blaSHV and blaCTX-M were detected in 1/8 (12.5%) of E. coli O157:H7 and blaTEM 3/8 (37.5%) respectively. Only 1 genotyped human Escherichia coli .0157:H7 clustered with beef strain There is evidence of blaTEM encoded E. coli O157:H7 causing infection in human from food animals retailed in many markets within various communities. Therefore, urgent surveillance with public health education, food, and environmental hygiene are highly needed to prevent its spread.","PeriodicalId":15987,"journal":{"name":"Journal of Immunoassay and Immunochemistry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89047393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-11-20DOI: 10.1080/15321819.2019.1689999
K. Kerboua, K. Djenouhat
ABSTRACT The discovery of the complement system was associated with the creation of medical serodiagnosis in the early 20th century. Its biotechnological applications, usable even a century after its development by Jules Bordet, preceded for decades the proof of its biochemical rather than biophysical nature. Complement science has begun to emerge, thanks to the labs of Michael Heidelberger and his student Manfred Martin Mayer. Complementology had known difficult moments like the suicide of Louis Pillemer by swallowing the reagents of his laboratory following the criticisms of his discovery by Robert A. Nelson, Jr., in March 1957, at the Walter Reed Army Institute. This alternative complement pathway continues to revolutionize medicine by its implications as the principal component of immunosurveillance and as an amplification loop for plasma proteolytic cascades. Moreover, the drug designed in pathologies related to this pathway, eculizumab, was the most expensive drug in the world at the beginning of its marketing. Complementology promises great hopes in inflammatory and degenerative diseases, regenerative medicine, transplantation, and vector nanotechnology and as a diagnostic tool primarily in transplantation and inflammatory imaging. The moral and historical responsibility requires to make known this legacy to the new generation of doctors and scientists and also the technicians of the clinical laboratory of complementology throughout the world.
补体系统的发现与20世纪早期医学血清诊断的产生有关。它在生物技术上的应用，甚至在儒勒·波德特(Jules bordt)发明它一个世纪之后，在证明其生化性质而非生物物理性质之前的几十年里，仍然可以使用。补体科学已经开始出现，这要感谢Michael Heidelberger和他的学生Manfred Martin Mayer的实验室。互补学也经历过艰难的时刻，比如1957年3月，小罗伯特·a·纳尔逊(Robert A. Nelson, Jr.)在沃尔特·里德陆军研究所批评路易斯·皮勒默(Louis Pillemer)的发现后，他吞下实验室的试剂自杀。这种替代补体途径作为免疫监视的主要成分和血浆蛋白水解级联的扩增环，继续给医学带来革命性的影响。此外，针对与该途径相关的病理设计的药物eculizumab在上市之初是世界上最昂贵的药物。互补学在炎症性和退行性疾病、再生医学、移植和载体纳米技术以及作为主要用于移植和炎症成像的诊断工具方面有着巨大的希望。道德和历史责任要求我们向全世界新一代的医生和科学家以及临床互补实验室的技术人员宣传这一遗产。
{"title":"Complementology’s foundation: The 100-year anniversary of the Nobel Prize to Jules Bordet","authors":"K. Kerboua, K. Djenouhat","doi":"10.1080/15321819.2019.1689999","DOIUrl":"https://doi.org/10.1080/15321819.2019.1689999","url":null,"abstract":"ABSTRACT The discovery of the complement system was associated with the creation of medical serodiagnosis in the early 20th century. Its biotechnological applications, usable even a century after its development by Jules Bordet, preceded for decades the proof of its biochemical rather than biophysical nature. Complement science has begun to emerge, thanks to the labs of Michael Heidelberger and his student Manfred Martin Mayer. Complementology had known difficult moments like the suicide of Louis Pillemer by swallowing the reagents of his laboratory following the criticisms of his discovery by Robert A. Nelson, Jr., in March 1957, at the Walter Reed Army Institute. This alternative complement pathway continues to revolutionize medicine by its implications as the principal component of immunosurveillance and as an amplification loop for plasma proteolytic cascades. Moreover, the drug designed in pathologies related to this pathway, eculizumab, was the most expensive drug in the world at the beginning of its marketing. Complementology promises great hopes in inflammatory and degenerative diseases, regenerative medicine, transplantation, and vector nanotechnology and as a diagnostic tool primarily in transplantation and inflammatory imaging. The moral and historical responsibility requires to make known this legacy to the new generation of doctors and scientists and also the technicians of the clinical laboratory of complementology throughout the world.","PeriodicalId":15987,"journal":{"name":"Journal of Immunoassay and Immunochemistry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75113991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-11-20DOI: 10.1080/15321819.2019.1694943
E. I. Yakupova, A. Bobylev, L. Bobyleva, I. Vikhlyantsev
ABSTRACT The giant muscle protein, titin, is the third most abundant protein in muscle (after myosin and actin). It was shown previously that smooth muscle titin (SMT) with a molecular mass of 500 kDa can form in vitro amorphous amyloid aggregates in two conditions: in solution of low ionic strength (0.15 M Glycine-KOH, pH 7.0) (SMT(Gly) aggregates) and in solution with ionic strength in the physiological range (0.2 M KCl, 20 mM imidazole, pH 7.2–7.4) (SMT(KCl) aggregates). Such aggregation in vivo, which may play a pathological or functional role, is not excluded. In view of the fact that some pathological amyloids can activate the classical and alternative pathways of complement system, we investigated the binding of complement component C1q and C3b to smooth muscle titin amyloid aggregates. The binding of С1q and C3b to SMT aggregates was not observed with ELISA assay. Since SMT aggregates do not activate the complement system, they are hardly implicated in the inflammatory process caused by muscle damage in amyloidoses. Abbreviations: SMT: smooth muscle titin; SMT(KCl) aggregates: SMT aggregates in solution containing 0.2 M KCl, 10 mM imidazole, pH 7.0; SMT(Gly) aggregates: SMT aggregates in solution containing 0.15 M glycine-KOH, pH 7.2-7.4; MAC: membrane attack complex; DLS: dynamic light scattering; NHS: Normal Human Serum
{"title":"Study of the complement activation by amyloid aggregates of smooth muscle titin in vitro","authors":"E. I. Yakupova, A. Bobylev, L. Bobyleva, I. Vikhlyantsev","doi":"10.1080/15321819.2019.1694943","DOIUrl":"https://doi.org/10.1080/15321819.2019.1694943","url":null,"abstract":"ABSTRACT The giant muscle protein, titin, is the third most abundant protein in muscle (after myosin and actin). It was shown previously that smooth muscle titin (SMT) with a molecular mass of 500 kDa can form in vitro amorphous amyloid aggregates in two conditions: in solution of low ionic strength (0.15 M Glycine-KOH, pH 7.0) (SMT(Gly) aggregates) and in solution with ionic strength in the physiological range (0.2 M KCl, 20 mM imidazole, pH 7.2–7.4) (SMT(KCl) aggregates). Such aggregation in vivo, which may play a pathological or functional role, is not excluded. In view of the fact that some pathological amyloids can activate the classical and alternative pathways of complement system, we investigated the binding of complement component C1q and C3b to smooth muscle titin amyloid aggregates. The binding of С1q and C3b to SMT aggregates was not observed with ELISA assay. Since SMT aggregates do not activate the complement system, they are hardly implicated in the inflammatory process caused by muscle damage in amyloidoses. Abbreviations: SMT: smooth muscle titin; SMT(KCl) aggregates: SMT aggregates in solution containing 0.2 M KCl, 10 mM imidazole, pH 7.0; SMT(Gly) aggregates: SMT aggregates in solution containing 0.15 M glycine-KOH, pH 7.2-7.4; MAC: membrane attack complex; DLS: dynamic light scattering; NHS: Normal Human Serum","PeriodicalId":15987,"journal":{"name":"Journal of Immunoassay and Immunochemistry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74258547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-11-18DOI: 10.1080/15321819.2019.1692029
Ghada Elsayed Elgarawany, A. Abdou, Doha Maher Taie, S. M. Motawea
ABSTRACT Acetaminophen is a common analgesic-antipyretic agent, which is safe in therapeutic doses but in higher doses can produce hepatic necrosis. The aim of this study is to investigate the hepatoprotective effects of artichoke, silymarin, and both agents in acetaminophen-induced liver damage in mice. Forty male mice were divided into five main groups, (1) control (2) Acetaminophen (APAP) (3) Artichoke leaf extracts (ALE) and APAP (4) silymarin and APAP group (5) ALE, silymarin and APAP groups. Blood samples were collected for the measurement of liver enzymes (ALT, AST, and ALP). The liver was excised, weighed and dissected into two parts, one used for measurement of malondialdehyde (MDA) and glutathione reductase, and the other part used for histopathological examination and assessment of proliferative cell nuclear antigen (PCNA) immunohistochemical expression. APAP group showed a significant increase in liver weight, ALT, AST, ALP, MDA, and PCNA expression with a significant decrease in glutathione reductase in comparison to control group. All these parameters were significantly improved in the three treated groups when compared to APAP group. APAP group showed marked portal inflammation and parenchyma necrosis. Co-administration of ALE and/or silymarin to acetaminophen treated mice showed a significant reduction in PCNA expression compared to APAP group. Both ALE and silymarin co-treatment showed a significant decrease in PCNA percentage to a level near to control group. Artichoke and/or silymarin are suggested to protect against acetaminophen-induced hepatotoxicity in mice by ameliorating liver enzymes, antioxidant effect, decreasing liver damage and proliferation. Abbreviation: ALT, alanine transaminase. AST, aspartate transaminase. ALP, alkaline phosphatase.MDA, malondialdehyde. PCNA, proliferative cell nuclear antigen
{"title":"Hepatoprotective effect of artichoke leaf extracts in comparison with silymarin on acetaminophen-induced hepatotoxicity in mice","authors":"Ghada Elsayed Elgarawany, A. Abdou, Doha Maher Taie, S. M. Motawea","doi":"10.1080/15321819.2019.1692029","DOIUrl":"https://doi.org/10.1080/15321819.2019.1692029","url":null,"abstract":"ABSTRACT Acetaminophen is a common analgesic-antipyretic agent, which is safe in therapeutic doses but in higher doses can produce hepatic necrosis. The aim of this study is to investigate the hepatoprotective effects of artichoke, silymarin, and both agents in acetaminophen-induced liver damage in mice. Forty male mice were divided into five main groups, (1) control (2) Acetaminophen (APAP) (3) Artichoke leaf extracts (ALE) and APAP (4) silymarin and APAP group (5) ALE, silymarin and APAP groups. Blood samples were collected for the measurement of liver enzymes (ALT, AST, and ALP). The liver was excised, weighed and dissected into two parts, one used for measurement of malondialdehyde (MDA) and glutathione reductase, and the other part used for histopathological examination and assessment of proliferative cell nuclear antigen (PCNA) immunohistochemical expression. APAP group showed a significant increase in liver weight, ALT, AST, ALP, MDA, and PCNA expression with a significant decrease in glutathione reductase in comparison to control group. All these parameters were significantly improved in the three treated groups when compared to APAP group. APAP group showed marked portal inflammation and parenchyma necrosis. Co-administration of ALE and/or silymarin to acetaminophen treated mice showed a significant reduction in PCNA expression compared to APAP group. Both ALE and silymarin co-treatment showed a significant decrease in PCNA percentage to a level near to control group. Artichoke and/or silymarin are suggested to protect against acetaminophen-induced hepatotoxicity in mice by ameliorating liver enzymes, antioxidant effect, decreasing liver damage and proliferation. Abbreviation: ALT, alanine transaminase. AST, aspartate transaminase. ALP, alkaline phosphatase.MDA, malondialdehyde. PCNA, proliferative cell nuclear antigen","PeriodicalId":15987,"journal":{"name":"Journal of Immunoassay and Immunochemistry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74615922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-10-21DOI: 10.1080/15321819.2019.1675694
A. Mustafa, A. Buentello, D. Gatlin, D. Lightner, M. Hume, A. Lawrence
ABSTRACT This study was designed to examine the effects of a prebiotic compound on the immune system, digestive tract histology, and stress physiology of shrimp. The specific effects of dietary supplementation of the prebiotic galactooligosaccharide (GOS or GTGOS) on shrimp health are scarce. This experiment, therefore attempted to evaluate the effects of GOS on growth, survival, intestinal microbiota, stress resistance and immune responses of Pacific white shrimp, Litopaneous vannamei. Over a 35-day trial, shrimps were fed diets, 15 times a day using automated feeder, supplemented with GOS at 0%, 0.25%, and 0.40% by weight. Shrimp survival and weight gain among the treatment groups were good but not significantly different (P > .05). Shrimp fed GOS-supplemented diets had reduced stress (glucose, P < .05) and increased immune responses (total hemocyte counts and phagocytic capacity, P < .05) compared to shrimps fed only basal diet with no supplementation. These results suggest that GOS not only changed the populations of gut microbiota but also reduced stress levels and enhanced immune response in shrimp.
{"title":"Dietary supplementation of galactooligosaccharides (GOS) in Pacific white shrimp, Litopenaeus vannamei, cultured in a recirculating system and its effects on gut microflora, growth, stress, and immune response","authors":"A. Mustafa, A. Buentello, D. Gatlin, D. Lightner, M. Hume, A. Lawrence","doi":"10.1080/15321819.2019.1675694","DOIUrl":"https://doi.org/10.1080/15321819.2019.1675694","url":null,"abstract":"ABSTRACT This study was designed to examine the effects of a prebiotic compound on the immune system, digestive tract histology, and stress physiology of shrimp. The specific effects of dietary supplementation of the prebiotic galactooligosaccharide (GOS or GTGOS) on shrimp health are scarce. This experiment, therefore attempted to evaluate the effects of GOS on growth, survival, intestinal microbiota, stress resistance and immune responses of Pacific white shrimp, Litopaneous vannamei. Over a 35-day trial, shrimps were fed diets, 15 times a day using automated feeder, supplemented with GOS at 0%, 0.25%, and 0.40% by weight. Shrimp survival and weight gain among the treatment groups were good but not significantly different (P > .05). Shrimp fed GOS-supplemented diets had reduced stress (glucose, P < .05) and increased immune responses (total hemocyte counts and phagocytic capacity, P < .05) compared to shrimps fed only basal diet with no supplementation. These results suggest that GOS not only changed the populations of gut microbiota but also reduced stress levels and enhanced immune response in shrimp.","PeriodicalId":15987,"journal":{"name":"Journal of Immunoassay and Immunochemistry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79347605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-10-11DOI: 10.1080/15321819.2019.1675695
S. Kumari, G. Saikumar, P. A. Desingu, T. Das, Rahul Singh
ABSTRACT We investigated immunohistochemical detection of porcine Sapelovirus (PSV) in naturally infected pigs of different ages. Forty-nine fecal samples, intestinal contents and other tissue samples from dead pigs were screened in previous study using reverse transcription polymerase chain reaction (RT-PCR) for PSV infection. Eight animals were positive for PSV based on RT-PCR examination. Gross lesions were recorded mainly in the large and small intestines. Microscopic examination of intestines showed severe enteritis. Tissue sections of all organs from PSV positive animals were immunostained using hyperimmune serum raised in rats against PSV that had been grown in a BHK-21 cell line. Staining of PSV was found only in the large and small intestines.
{"title":"Immunohistochemical detection of naturally occurring porcine Sapelovirus infection in Indian pigs","authors":"S. Kumari, G. Saikumar, P. A. Desingu, T. Das, Rahul Singh","doi":"10.1080/15321819.2019.1675695","DOIUrl":"https://doi.org/10.1080/15321819.2019.1675695","url":null,"abstract":"ABSTRACT We investigated immunohistochemical detection of porcine Sapelovirus (PSV) in naturally infected pigs of different ages. Forty-nine fecal samples, intestinal contents and other tissue samples from dead pigs were screened in previous study using reverse transcription polymerase chain reaction (RT-PCR) for PSV infection. Eight animals were positive for PSV based on RT-PCR examination. Gross lesions were recorded mainly in the large and small intestines. Microscopic examination of intestines showed severe enteritis. Tissue sections of all organs from PSV positive animals were immunostained using hyperimmune serum raised in rats against PSV that had been grown in a BHK-21 cell line. Staining of PSV was found only in the large and small intestines.","PeriodicalId":15987,"journal":{"name":"Journal of Immunoassay and Immunochemistry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73499517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-26DOI: 10.1080/15321819.2019.1671861
Jackie Boxer, Sarah Weddell, David Broomhead, C. Hogg, Sarah Johnson
ABSTRACT The objectives of this study were to investigate the usability and performance of seven visual home pregnancy tests, available in Europe. Part one of the study was home-based and involved volunteers testing a selection of four home pregnancy tests. The tests used and order of use were randomized. Part two, performed at a study site, involved volunteers reading and interpreting the results of the same selection of home pregnancy tests used in part one, but using urine standards representing early pregnancy (25 mIU/mL human chorionic gonadotropin) or a ‘not pregnant’ (0 mIU/mL human chorionic gonadotropin) sample. The volunteers completed a questionnaire after each test in both parts. Three of the seven tests met their accuracy/reliability claims: tests A (99.8%), B (100%), and F (97.6%) (not statistically different from the claimed 99% accuracy). The remaining four tests had accuracies/reliabilities of <99% at 81.6% (C), 89.0% (E), 92.5% (D), and 95.9% (G), respectively. Test A was the highest-rated test for each attribute tested in both settings. Test D was ranked the lowest in part one and test C was ranked lowest overall for part two. Home pregnancy tests vary in performance and usability, therefore requiring better standardization and performance evaluation in Europe. Clinical Trials Reference Number: NCT03589534
{"title":"Home pregnancy tests in the hands of the intended user","authors":"Jackie Boxer, Sarah Weddell, David Broomhead, C. Hogg, Sarah Johnson","doi":"10.1080/15321819.2019.1671861","DOIUrl":"https://doi.org/10.1080/15321819.2019.1671861","url":null,"abstract":"ABSTRACT The objectives of this study were to investigate the usability and performance of seven visual home pregnancy tests, available in Europe. Part one of the study was home-based and involved volunteers testing a selection of four home pregnancy tests. The tests used and order of use were randomized. Part two, performed at a study site, involved volunteers reading and interpreting the results of the same selection of home pregnancy tests used in part one, but using urine standards representing early pregnancy (25 mIU/mL human chorionic gonadotropin) or a ‘not pregnant’ (0 mIU/mL human chorionic gonadotropin) sample. The volunteers completed a questionnaire after each test in both parts. Three of the seven tests met their accuracy/reliability claims: tests A (99.8%), B (100%), and F (97.6%) (not statistically different from the claimed 99% accuracy). The remaining four tests had accuracies/reliabilities of <99% at 81.6% (C), 89.0% (E), 92.5% (D), and 95.9% (G), respectively. Test A was the highest-rated test for each attribute tested in both settings. Test D was ranked the lowest in part one and test C was ranked lowest overall for part two. Home pregnancy tests vary in performance and usability, therefore requiring better standardization and performance evaluation in Europe. Clinical Trials Reference Number: NCT03589534","PeriodicalId":15987,"journal":{"name":"Journal of Immunoassay and Immunochemistry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72615451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-26DOI: 10.1080/15321819.2019.1671862
Lamplaimas Tangpan, Tippawadee Jansai, Sasiwan Kerdpoo, Tiemjan Kiewkarnkha, Ekthong Limweeraprajak, T. Tatu
ABSTRACT The monoclonal antibody (mAb) against γ-globin chain clone Thal N/B was produced. It was aimed at measuring the quantity of HbF (α2γ2)-containing red blood cells or F cells by flow cytometry. However, it may cross-react with Hb Bart’s (γ4) which is present in the SEA-α thalassemia 1 trait. We measured FC levels by flow cytometry using this in-house mAb for 100 blood samples. Prevalence of high FC trait in this cohort was 51%. Ten of 12 SEA-α thalassemia 1 trait were included in the 51% high FC individuals. Comparing FC levels in the 51 high FC individuals having and not having the SEA-α thalassemia 1 trait showed no difference of FC levels. It was concluded that Hb Bart’s did not interfere with FC measurement by flow cytometry using the in-house Thal N/B mAb. Therefore, it can be used for measuring F cell levels in regions having a high prevalence of the SEA-α thalassemia 1 trait. The findings of this research should apply to other clones of anti-γ-globin chain mAb that are aimed for HbF/FC quantification.
{"title":"The in-house monoclonal antibody against γ-globin chain; Thal N/B, accurately measured F cells in SEA-α thalassemia 1 trait","authors":"Lamplaimas Tangpan, Tippawadee Jansai, Sasiwan Kerdpoo, Tiemjan Kiewkarnkha, Ekthong Limweeraprajak, T. Tatu","doi":"10.1080/15321819.2019.1671862","DOIUrl":"https://doi.org/10.1080/15321819.2019.1671862","url":null,"abstract":"ABSTRACT The monoclonal antibody (mAb) against γ-globin chain clone Thal N/B was produced. It was aimed at measuring the quantity of HbF (α2γ2)-containing red blood cells or F cells by flow cytometry. However, it may cross-react with Hb Bart’s (γ4) which is present in the SEA-α thalassemia 1 trait. We measured FC levels by flow cytometry using this in-house mAb for 100 blood samples. Prevalence of high FC trait in this cohort was 51%. Ten of 12 SEA-α thalassemia 1 trait were included in the 51% high FC individuals. Comparing FC levels in the 51 high FC individuals having and not having the SEA-α thalassemia 1 trait showed no difference of FC levels. It was concluded that Hb Bart’s did not interfere with FC measurement by flow cytometry using the in-house Thal N/B mAb. Therefore, it can be used for measuring F cell levels in regions having a high prevalence of the SEA-α thalassemia 1 trait. The findings of this research should apply to other clones of anti-γ-globin chain mAb that are aimed for HbF/FC quantification.","PeriodicalId":15987,"journal":{"name":"Journal of Immunoassay and Immunochemistry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82592224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-22DOI: 10.1080/15321819.2019.1669640
Ganiyu Adetunji Adeniran, O. G. Ohore, T. Jarikre, Olawale Olawumi Ola, V. Oyebanji, B. Emikpe
ABSTRACT The emergence of antigenic variants and very virulent strains of infectious bursa disease virus (IBDV) in vaccinated flocks considerably stimulated research in IBDV vaccine administration. The mucoadhesive and immunopotentials of Cedrela odorata and Khaya senegalensis were explored in vaccine delivery against clinical IBDV in broiler chickens. A total of 400 chicks were successfully brooded and raised from day old for commencement of this experiment. The birds were randomly distributed into eight groups with an average of 50 birds per group comprising: Gums-Gumboro Vaccine Ocular (infected) (GGVOC), Gumboro Vaccine alone Ocular (infected) (GVOC), Gums alone Ocular (infected) (GOC), Gums-Gumboro Vaccine Oral (infected) (GGVOR), Gumboro Vaccine alone Oral (infected) (GVOR), Gums alone Oral (infected) (GOR), No-Vaccine-No-Gums (infected) (NVNG/i), and No-Vaccine-No-Gums (not infected) (NVNG). On a weekly basis, 1.5mls of blood were collected from 5 birds and 3 birds euthanized per group for serological analysis and mucosal washings (trachea and intestine) respectively. Data obtained were analyzed and sample to positive ratio calculated. The post 1st vaccination trachea IgG antibody response was moderately higher in the ocular groups than the oral groups. It was also high in the VOC, GVOC, GOC, VOR groups than the GVOR groups. The antibody response (IgG) pre and post 1st vaccination, post 2nd vaccination and post infection from serum, trachea and intestinal washes showed that by week 1 Post 1st vaccination, there was insignificant increase in titer serum response of the gum-vaccine ocular group compared to the vaccine ocular alone while both groups were insignificantly higher than the oral group. Overall, serum titer showed a rapid response with spiked significant response by 48h pi in the gum vaccine groups (especially GVOR), which peaks by day 3 and remains insignificantly higher throughout the day 7 pi compared to vaccine alone groups. In conclusion, use of the mucilage from C. odorata and K. senegalenses in equal proportion has given better enhancement of the response to IBDV vaccination and premise for further investigations for improvement against IBD.
{"title":"Humoral and mucosal immune responses in challenged chickens vaccinated with Infectious bursal disease vaccine using gums from Cedrela odorata and Khaya senegalensis as delivery agents","authors":"Ganiyu Adetunji Adeniran, O. G. Ohore, T. Jarikre, Olawale Olawumi Ola, V. Oyebanji, B. Emikpe","doi":"10.1080/15321819.2019.1669640","DOIUrl":"https://doi.org/10.1080/15321819.2019.1669640","url":null,"abstract":"ABSTRACT The emergence of antigenic variants and very virulent strains of infectious bursa disease virus (IBDV) in vaccinated flocks considerably stimulated research in IBDV vaccine administration. The mucoadhesive and immunopotentials of Cedrela odorata and Khaya senegalensis were explored in vaccine delivery against clinical IBDV in broiler chickens. A total of 400 chicks were successfully brooded and raised from day old for commencement of this experiment. The birds were randomly distributed into eight groups with an average of 50 birds per group comprising: Gums-Gumboro Vaccine Ocular (infected) (GGVOC), Gumboro Vaccine alone Ocular (infected) (GVOC), Gums alone Ocular (infected) (GOC), Gums-Gumboro Vaccine Oral (infected) (GGVOR), Gumboro Vaccine alone Oral (infected) (GVOR), Gums alone Oral (infected) (GOR), No-Vaccine-No-Gums (infected) (NVNG/i), and No-Vaccine-No-Gums (not infected) (NVNG). On a weekly basis, 1.5mls of blood were collected from 5 birds and 3 birds euthanized per group for serological analysis and mucosal washings (trachea and intestine) respectively. Data obtained were analyzed and sample to positive ratio calculated. The post 1st vaccination trachea IgG antibody response was moderately higher in the ocular groups than the oral groups. It was also high in the VOC, GVOC, GOC, VOR groups than the GVOR groups. The antibody response (IgG) pre and post 1st vaccination, post 2nd vaccination and post infection from serum, trachea and intestinal washes showed that by week 1 Post 1st vaccination, there was insignificant increase in titer serum response of the gum-vaccine ocular group compared to the vaccine ocular alone while both groups were insignificantly higher than the oral group. Overall, serum titer showed a rapid response with spiked significant response by 48h pi in the gum vaccine groups (especially GVOR), which peaks by day 3 and remains insignificantly higher throughout the day 7 pi compared to vaccine alone groups. In conclusion, use of the mucilage from C. odorata and K. senegalenses in equal proportion has given better enhancement of the response to IBDV vaccination and premise for further investigations for improvement against IBD.","PeriodicalId":15987,"journal":{"name":"Journal of Immunoassay and Immunochemistry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82253854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-21DOI: 10.1080/15321819.2019.1669639
E. Ezenduka, O. J. Okorie-Kanu, J. A. Nwanta
ABSTRACT The validity of two microbiological methods: Tube (Premi® Test) and Plate (Three Plate Test) Test for the detection of oxytetracycline (OTC) in poultry was done using Enzyme Linked Immunosorbent Assay (ELISA) immunoassay as gold standard. OTC was administered to two groups of birds: intramuscular drug administration (group A) and oral drug administration (group B). Liver and muscle tissue samples from birds in both groups were tested for the presence of OTCwith the Four Plate Test (FPT), Premi® Test and ELISA. For muscle tissues, FPT had a sensitivity of 71.4% and 60%, while Premi® Test had a sensitivity of 57% and 20% for intramuscular and orally treated birds, respectively. For the liver tissues, FPT had 87.5% and 83.5% while Premi® Test had 37.5% and 16.6% sensitivity for intramuscular and orally treated birds, respectively. The two tests had 100% specificity for OTC in tissues of birds from both treatment groups. There is a strong correlation (r = 0.93) between the inhibition zones of FPT and ELISA concentrations in OTC detection. FPT, therefore, has a higher sensitivity for OTC than Premi® Test.
{"title":"Comparative analysis of two microbiological tests in the detection of oxytetracycline residue in chicken using ELISA as gold standard","authors":"E. Ezenduka, O. J. Okorie-Kanu, J. A. Nwanta","doi":"10.1080/15321819.2019.1669639","DOIUrl":"https://doi.org/10.1080/15321819.2019.1669639","url":null,"abstract":"ABSTRACT The validity of two microbiological methods: Tube (Premi® Test) and Plate (Three Plate Test) Test for the detection of oxytetracycline (OTC) in poultry was done using Enzyme Linked Immunosorbent Assay (ELISA) immunoassay as gold standard. OTC was administered to two groups of birds: intramuscular drug administration (group A) and oral drug administration (group B). Liver and muscle tissue samples from birds in both groups were tested for the presence of OTCwith the Four Plate Test (FPT), Premi® Test and ELISA. For muscle tissues, FPT had a sensitivity of 71.4% and 60%, while Premi® Test had a sensitivity of 57% and 20% for intramuscular and orally treated birds, respectively. For the liver tissues, FPT had 87.5% and 83.5% while Premi® Test had 37.5% and 16.6% sensitivity for intramuscular and orally treated birds, respectively. The two tests had 100% specificity for OTC in tissues of birds from both treatment groups. There is a strong correlation (r = 0.93) between the inhibition zones of FPT and ELISA concentrations in OTC detection. FPT, therefore, has a higher sensitivity for OTC than Premi® Test.","PeriodicalId":15987,"journal":{"name":"Journal of Immunoassay and Immunochemistry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77045741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：